Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

16.06
-0.2500-1.53%
Post-market: 16.080.0200+0.12%19:54 EDT
Volume:12.14M
Turnover:195.37M
Market Cap:18.42B
PE:-14.06
High:16.49
Open:16.35
Low:15.95
Close:16.31
Loading ...

Teva (TEVA) Gets a Buy from Leader Capital Markets

TIPRANKS
·
1 hour ago

Goldman Sachs Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)

TIPRANKS
·
16 Jul

Teva Pharmaceutical’s Austedo Poised for Growth: Analyst Recommends Buy Rating

TIPRANKS
·
15 Jul

Leader Capital Markets Sticks to Its Buy Rating for Teva (TEVA)

TIPRANKS
·
15 Jul

Leader Capital Markets Reaffirms Their Buy Rating on Teva (TEVA)

TIPRANKS
·
12 Jul

Teva (TEVA) Receives a Buy from Leader Capital Markets

TIPRANKS
·
08 Jul

Leader Capital Markets Keeps Their Buy Rating on Teva (TEVA)

TIPRANKS
·
05 Jul

Leader Capital Markets Remains a Buy on Teva (TEVA)

TIPRANKS
·
01 Jul

Leader Capital Markets Sticks to Its Buy Rating for Teva (TEVA)

TIPRANKS
·
28 Jun

Teva Pharmaceuticals : UBS Cuts Target Price to $23 From $24

THOMSON REUTERS
·
27 Jun

Teva Releases Q2 2025 Aide Memoire

THOMSON REUTERS
·
27 Jun

Teva Pharmaceuticals Is Maintained at Buy by UBS

Dow Jones
·
26 Jun

Leader Capital Markets Remains a Buy on Teva (TEVA)

TIPRANKS
·
21 Jun

Teva Pharmaceutical’s Strategic Edge and Growth Potential: Analyst Recommends Buy Rating

TIPRANKS
·
18 Jun

Teva (TEVA) Gets a Buy from Leader Capital Markets

TIPRANKS
·
17 Jun

Teva, Fosun Pharma partner to develop TEV-56278

TIPRANKS
·
16 Jun

Leader Capital Markets Reaffirms Their Buy Rating on Teva (TEVA)

TIPRANKS
·
14 Jun

Teva put volume heavy and directionally bearish

TIPRANKS
·
14 Jun

Leader Capital Markets Reaffirms Their Buy Rating on Teva (TEVA)

TIPRANKS
·
10 Jun

Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Johnson & Johnson (JNJ) and Design Therapeutics (DSGN)

TIPRANKS
·
09 Jun